Literature DB >> 20952453

The incidence and associated risk factors for sudden unexplained death in psychiatric in-patients in England and Wales.

Kirsten Windfuhr1, Pauline Turnbull, David While, Nicola Swinson, Hetal Mehta, Kelly Hadfield, Urara Hiroeh, Helen Watkinson, Clare Dixon, Sandra Flynn, Simon Thomas, Glyn Lewis, I N Ferrier, Tim Amos, Petros Skapinakis, Jenny Shaw, Nav Kapur, Louis Appleby.   

Abstract

Clinical characteristics and risk factors associated with sudden unexplained death (SUD) in the psychiatric population are unclear. Psychiatric in-patients (England, Wales) who met criteria for SUD were identified (1 March 1999-31 December 2005). Cases were matched with controls (in-patients alive on the day a SUD occurred). Data were collected via questionnaires. Some 283 cases of SUD were identified (41 annually), with a rate of 2.33/10,000 mental health admissions (in England). Electrocardiograms were not routine, cardiopulmonary resuscitation equipment was sometimes unavailable, attempts to resuscitate patients were carried out on one-half of all patients and post mortems/inquiries were not routine. Restraint and seclusion were uncommon. Risk factors included: benzodiazepines (odds ratio (OR): 1.83); ≥ 2 antipsychotics (OR: 2.35); promazine (OR: 4.02); diazepam (OR: 1.71); clozapine (OR: 2.10); cardiovascular disease (OR: 2.00); respiratory disease (OR: 1.98); diagnosis of dementia (OR: 2.08). Venlafaxine and a diagnosis of affective disorder were associated with reduced ORs (OR: 0.42; OR: 0.65). SUD is relatively rare, although it is more common in older patients and males. Prevention measures may include safer prescribing of antipsychotics and improved physical health care. The contribution of restraint or seclusion to SUD in individual cases is unclear. A uniform definition of SUD may help to identify contributing factors.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20952453     DOI: 10.1177/0269881110379288

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  7 in total

1.  Consumption of pharmaceuticals in primary non-Alzheimer's degenerative dementias : a cross-sectional study by the Registry of Dementias of Girona (ReDeGi).

Authors:  Secundino López-Pousa; Oriol Turró-Garriga; Laia Calvó-Perxas; Olga Carmona; Jordi Gich; Elisabet Alsina; Fabià Màrquez; Marta Viñas; Josefa Turbau; Joan Vilalta-Franch; Anna Maria Roig; Josep Garre-Olmo
Journal:  Drugs Aging       Date:  2012-09       Impact factor: 3.923

2.  Long-term use of benzodiazepines in older patients in Germany: a retrospective analysis.

Authors:  Louis Jacob; Michael A Rapp; Karel Kostev
Journal:  Ther Adv Psychopharmacol       Date:  2017-03-01

Review 3.  The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach.

Authors:  Christoffer Polcwiartek; Benjamin Sneider; Claus Graff; David Taylor; Jonathan Meyer; Jørgen K Kanters; Jimmi Nielsen
Journal:  Psychopharmacology (Berl)       Date:  2015-08-01       Impact factor: 4.530

4.  Validation of a claims-based antipsychotic polypharmacy measure.

Authors:  Emily Leckman-Westin; Edith Kealey; Nitin Gupta; Qingxian Chen; Tobias Gerhard; Stephen Crystal; Mark Olfson; Molly Finnerty
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-03-24       Impact factor: 2.890

5.  Prescribing patterns in dementia: a multicentre observational study in a German network of CAM physicians.

Authors:  Elke Jeschke; Thomas Ostermann; Horst C Vollmar; Manuela Tabali; Friedemann Schad; Harald Matthes
Journal:  BMC Neurol       Date:  2011-08-08       Impact factor: 2.474

6.  Development of a Web-Based Clinical Decision Support System for Drug Prescription: Non-Interventional Naturalistic Description of the Antipsychotic Prescription Patterns in 4345 Outpatients and Future Applications.

Authors:  Sofian Berrouiguet; Maria Luisa Barrigón; Sara A Brandt; Santiago Ovejero-García; Raquel Álvarez-García; Juan Jose Carballo; Philippe Lenca; Philippe Courtet; Enrique Baca-García
Journal:  PLoS One       Date:  2016-10-20       Impact factor: 3.240

7.  A case report of acute hypothermia during initial inpatient clozapine titration with review of current literature on clozapine-induced temperature dysregulations.

Authors:  Bradley G Burk; Alex H Ward; Brooke Clark
Journal:  BMC Psychiatry       Date:  2020-06-09       Impact factor: 3.630

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.